We Transform Tech Businesses
£150k-£3m
9 Current Investments
Tech-Focussed
At Koodos, we invest in ambitious tech startups, providing the capital and support needed to fuel their growth. Our focus is on scalable companies in marketplaces, platforms, and software (SaaS) sectors.
What we do
We invest in and advise high-potential businesses undergoing transformation. Whether a company is distressed, underperforming, or struggling to scale, we step in with the expertise, capital, and strategic direction to turn things around.
Our model is simple: we partner with founders and management teams, working hands-on to restructure operations, optimise financials, and drive sustainable growth. The goal? Rapid recovery and high value exits within 2-3 years, whether through acquisitions, mergers, or private sales.
We focus on companies with strong fundamentals but untapped potential—businesses that need the right strategy, funding, and execution to succeed.
Current Investments
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
PreComb
PreComb collaborates with research partners by providing expert guidance in selecting and generating patient-derived 3D tumor models tailored to their studies.
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
Bricksave
A state-of-the-art crowdfunding platform providing direct access to secure, asset-backed investment opportunities hand-picked from across the globe.
BVNK
BVNK provides stablecoin payments infrastructure, unifying banks and blockchains in a single API platform, to accelerate global money movement.
Pocket Planet
Pocket Planet will be the UK's largest indoor miniature world, an immersive experience taking visitors on a journey through the UK & around the world.
ReBio
ReBio is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve.
CEBINA
A dynamic and forward-thinking organization, their mission is to foster the growth of early-stage life sciences ventures, cultivating innovation and advancing breakthroughs in medicine and technology.
Team
Nat Hutley
Partner
Leads the advisory business, working hands-on with founders to execute operational and financial transformations.
Iain Hubert
Partner
Heads fundraising and investor relations, ensuring the right capital partners are brought on board.
Galen Moore
Advisor
Oversees operations, strategy and execution to ensure businesses receive hands-on support.
Val Hutley
Junior Sales Associate
Focused on investor engagement and deal origination, helping to expand Koodos' network of self-certified and institutional investors.
Charles Agar
Junior Sales Associate
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Benjamin Harrison
Fundraising
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Establishing Koodos
Koodos transitions from a seed investment firm to a specialist advisory and investment platform, focusing on turnarounds and high-growth businesses.
We began by investing alongside family offices, co-investing in distressed and restructuring opportunities.
Expanding Fundraising Capabilities
Fundraising division launches, enabling self-certified investors to access high-potential distressed businesses. Built a network of introducers and brokers to scale investor access and expand deal flow.
Laying the Groundwork for Direct Investment
Strengthened focus on healthcare, biotech, and consumer growth businesses, identifying key opportunities for direct investment in 2024.
Investing in Life Sciences
2CureX partnership – Koodos begins supporting the precision oncology firm, leveraging its network to drive investor engagement and capital structuring.
Koodos invests in PreComb, a precision oncology driven genoid testing company, and actively supports its Series A fundraising.
Focus: Investor introductions, capital structuring, and strategic positioning.
Institutional Capital Discussions
Institutional investor interest in precision oncology businesses – potential £7m+ allocation for Koodos-backed companies.
Strengthening relationships with family offices and private equity investors.
Investing in Pocket Planet
Pocket Planet joins the portfolio – Koodos structures a carried interest agreement, securing long-term alignment on exit upside.
Focus: Market positioning, capital efficiency, and long-term scalability.
Scaling for Growth
Expanding the portfolio to 10+ businesses across biotech, consumer, and deep tech.
Transitioning towards a £50m dedicated fund to drive larger investments
Structuring faster, high value exits for existing investments.
We Transform Tech Businesses
£150k-£3m
9 Current Investments
Tech-Focussed
At Koodos, we invest in ambitious tech startups, providing the capital and support needed to fuel their growth. Our focus is on scalable companies in marketplaces, platforms, and software (SaaS) sectors.
What we do
We invest in and advise high-potential businesses undergoing transformation. Whether a company is distressed, underperforming, or struggling to scale, we step in with the expertise, capital, and strategic direction to turn things around.
Our model is simple: we partner with founders and management teams, working hands-on to restructure operations, optimise financials, and drive sustainable growth. The goal? Rapid recovery and high value exits within 2-3 years, whether through acquisitions, mergers, or private sales.
We focus on companies with strong fundamentals but untapped potential—businesses that need the right strategy, funding, and execution to succeed.
Current Investments
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
PreComb
PreComb collaborates with research partners by providing expert guidance in selecting and generating patient-derived 3D tumor models tailored to their studies.
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
Bricksave
A state-of-the-art crowdfunding platform providing direct access to secure, asset-backed investment opportunities hand-picked from across the globe.
BVNK
BVNK provides stablecoin payments infrastructure, unifying banks and blockchains in a single API platform, to accelerate global money movement.
Pocket Planet
Pocket Planet will be the UK's largest indoor miniature world, an immersive experience taking visitors on a journey through the UK & around the world.
ReBio
ReBio is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve.
CEBINA
A dynamic and forward-thinking organization, their mission is to foster the growth of early-stage life sciences ventures, cultivating innovation and advancing breakthroughs in medicine and technology.
Team
Nat Hutley
Partner
Leads the advisory business, working hands-on with founders to execute operational and financial transformations.
Iain Hubert
Partner
Heads fundraising and investor relations, ensuring the right capital partners are brought on board.
Galen Moore
Advisor
Oversees operations, strategy and execution to ensure businesses receive hands-on support.
Val Hutley
Junior Sales Associate
Focused on investor engagement and deal origination, helping to expand Koodos' network of self-certified and institutional investors.
Charles Agar
Junior Sales Associate
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Benjamin Harrison
Fundraising
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Establishing Koodos
Koodos transitions from a seed investment firm to a specialist advisory and investment platform, focusing on turnarounds and high-growth businesses.
We began by investing alongside family offices, co-investing in distressed and restructuring opportunities.
Expanding Fundraising Capabilities
Fundraising division launches, enabling self-certified investors to access high-potential distressed businesses. Built a network of introducers and brokers to scale investor access and expand deal flow.
Laying the Groundwork for Direct Investment
Strengthened focus on healthcare, biotech, and consumer growth businesses, identifying key opportunities for direct investment in 2024.
Investing in Life Sciences
2CureX partnership – Koodos begins supporting the precision oncology firm, leveraging its network to drive investor engagement and capital structuring.
Koodos invests in PreComb, a precision oncology driven genoid testing company, and actively supports its Series A fundraising.
Focus: Investor introductions, capital structuring, and strategic positioning.
Institutional Capital Discussions
Institutional investor interest in precision oncology businesses – potential £7m+ allocation for Koodos-backed companies.
Strengthening relationships with family offices and private equity investors.
Investing in Pocket Planet
Pocket Planet joins the portfolio – Koodos structures a carried interest agreement, securing long-term alignment on exit upside.
Focus: Market positioning, capital efficiency, and long-term scalability.
Scaling for Growth
Expanding the portfolio to 10+ businesses across biotech, consumer, and deep tech.
Transitioning towards a £50m dedicated fund to drive larger investments
Structuring faster, high value exits for existing investments.
We Transform Tech Businesses
£150k-£3m
9 Current Investments
Tech-Focussed
At Koodos, we invest in ambitious tech startups, providing the capital and support needed to fuel their growth. Our focus is on scalable companies in marketplaces, platforms, and software (SaaS) sectors.
What we do
We invest in and advise high-potential businesses undergoing transformation. Whether a company is distressed, underperforming, or struggling to scale, we step in with the expertise, capital, and strategic direction to turn things around.
Our model is simple: we partner with founders and management teams, working hands-on to restructure operations, optimise financials, and drive sustainable growth. The goal? Rapid recovery and high value exits within 2-3 years, whether through acquisitions, mergers, or private sales.
We focus on companies with strong fundamentals but untapped potential—businesses that need the right strategy, funding, and execution to succeed.
Current Investments
2cureX
2cureX is pioneering the use of functional drug sensitivity testing to improve the outcome of cancer treatments.
PreComb
PreComb collaborates with research partners by providing expert guidance in selecting and generating patient-derived 3D tumor models tailored to their studies.
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
Bricksave
A state-of-the-art crowdfunding platform providing direct access to secure, asset-backed investment opportunities hand-picked from across the globe.
BVNK
BVNK provides stablecoin payments infrastructure, unifying banks and blockchains in a single API platform, to accelerate global money movement.
Pocket Planet
Pocket Planet will be the UK's largest indoor miniature world, an immersive experience taking visitors on a journey through the UK & around the world.
ReBio
ReBio is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve.
CEBINA
A dynamic and forward-thinking organization, their mission is to foster the growth of early-stage life sciences ventures, cultivating innovation and advancing breakthroughs in medicine and technology.
Team
Nat Hutley
Partner
Leads the advisory business, working hands-on with founders to execute operational and financial transformations.
Iain Hubert
Partner
Heads fundraising and investor relations, ensuring the right capital partners are brought on board.
Galen Moore
Advisor
Oversees operations, strategy and execution to ensure businesses receive hands-on support.
Val Hutley
Junior Sales Associate
Focused on investor engagement and deal origination, helping to expand Koodos' network of self-certified and institutional investors.
Charles Agar
Junior Sales Associate
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Benjamin Harrison
Fundraising
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Establishing Koodos
Koodos transitions from a seed investment firm to a specialist advisory and investment platform, focusing on turnarounds and high-growth businesses.
We began by investing alongside family offices, co-investing in distressed and restructuring opportunities.
Expanding Fundraising Capabilities
Fundraising division launches, enabling self-certified investors to access high-potential distressed businesses. Built a network of introducers and brokers to scale investor access and expand deal flow.
Laying the Groundwork for Direct Investment
Strengthened focus on healthcare, biotech, and consumer growth businesses, identifying key opportunities for direct investment in 2024.
Investing in Life Sciences
2CureX partnership – Koodos begins supporting the precision oncology firm, leveraging its network to drive investor engagement and capital structuring.
Koodos invests in PreComb, a precision oncology driven genoid testing company, and actively supports its Series A fundraising.
Focus: Investor introductions, capital structuring, and strategic positioning.
Institutional Capital Discussions
Institutional investor interest in precision oncology businesses – potential £7m+ allocation for Koodos-backed companies.
Strengthening relationships with family offices and private equity investors.
Investing in Pocket Planet
Pocket Planet joins the portfolio – Koodos structures a carried interest agreement, securing long-term alignment on exit upside.
Focus: Market positioning, capital efficiency, and long-term scalability.
Scaling for Growth
Expanding the portfolio to 10+ businesses across biotech, consumer, and deep tech.
Transitioning towards a £50m dedicated fund to drive larger investments
Structuring faster, high value exits for existing investments.
Menu
Close
We Transform Tech Businesses
£150k-£3m
9 Current Investments
Tech-Focussed
At Koodos, we invest in ambitious tech startups, providing the capital and support needed to fuel their growth. Our focus is on scalable companies in marketplaces, platforms, and software (SaaS) sectors.
What we do
We invest in and advise high-potential businesses undergoing transformation. Whether a company is distressed, underperforming, or struggling to scale, we step in with the expertise, capital, and strategic direction to turn things around.
Our model is simple: we partner with founders and management teams, working hands-on to restructure operations, optimise financials, and drive sustainable growth. The goal? Rapid recovery and high value exits within 2-3 years, whether through acquisitions, mergers, or private sales.
We focus on companies with strong fundamentals but untapped potential—businesses that need the right strategy, funding, and execution to succeed.
Current Investments
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
PreComb
PreComb collaborates with research partners by providing expert guidance in selecting and generating patient-derived 3D tumor models tailored to their studies.
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
Bricksave
A state-of-the-art crowdfunding platform providing direct access to secure, asset-backed investment opportunities hand-picked from across the globe.
BVNK
BVNK provides stablecoin payments infrastructure, unifying banks and blockchains in a single API platform, to accelerate global money movement.
Pocket Planet
Pocket Planet will be the UK's largest indoor miniature world, an immersive experience taking visitors on a journey through the UK & around the world.
ReBio
ReBio is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve.
CEBINA
A dynamic and forward-thinking organization, their mission is to foster the growth of early-stage life sciences ventures, cultivating innovation and advancing breakthroughs in medicine and technology.
Team
Nat Hutley
Partner
Leads the advisory business, working hands-on with founders to execute operational and financial transformations.
Iain Hubert
Partner
Heads fundraising and investor relations, ensuring the right capital partners are brought on board.
Galen Moore
Advisor
Oversees operations, strategy and execution to ensure businesses receive hands-on support.
Val Hutley
Junior Sales Associate
Focused on investor engagement and deal origination, helping to expand Koodos' network of self-certified and institutional investors.
Charles Agar
Junior Sales Associate
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Benjamin Harrison
Fundraising
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Establishing Koodos
Koodos transitions from a seed investment firm to a specialist advisory and investment platform, focusing on turnarounds and high-growth businesses.
We began by investing alongside family offices, co-investing in distressed and restructuring opportunities.
Expanding Fundraising Capabilities
Fundraising division launches, enabling self-certified investors to access high-potential distressed businesses. Built a network of introducers and brokers to scale investor access and expand deal flow.
Laying the Groundwork for Direct Investment
Strengthened focus on healthcare, biotech, and consumer growth businesses, identifying key opportunities for direct investment in 2024.
Investing in Life Sciences
2CureX partnership – Koodos begins supporting the precision oncology firm, leveraging its network to drive investor engagement and capital structuring.
Koodos invests in PreComb, a precision oncology driven genoid testing company, and actively supports its Series A fundraising.
Focus: Investor introductions, capital structuring, and strategic positioning.
Institutional Capital Discussions
Institutional investor interest in precision oncology businesses – potential £7m+ allocation for Koodos-backed companies.
Strengthening relationships with family offices and private equity investors.
Investing in Pocket Planet
Pocket Planet joins the portfolio – Koodos structures a carried interest agreement, securing long-term alignment on exit upside.
Focus: Market positioning, capital efficiency, and long-term scalability.
Scaling for Growth
Expanding the portfolio to 10+ businesses across biotech, consumer, and deep tech.
Transitioning towards a £50m dedicated fund to drive larger investments
Structuring faster, high value exits for existing investments.
We Transform Tech Businesses
£150k-£3m
9 Current Investments
Tech-Focussed
At Koodos, we invest in ambitious tech startups, providing the capital and support needed to fuel their growth. Our focus is on scalable companies in marketplaces, platforms, and software (SaaS) sectors.
What we do
We invest in and advise high-potential businesses undergoing transformation. Whether a company is distressed, underperforming, or struggling to scale, we step in with the expertise, capital, and strategic direction to turn things around.
Our model is simple: we partner with founders and management teams, working hands-on to restructure operations, optimise financials, and drive sustainable growth. The goal? Rapid recovery and high value exits within 2-3 years, whether through acquisitions, mergers, or private sales.
We focus on companies with strong fundamentals but untapped potential—businesses that need the right strategy, funding, and execution to succeed.
Current Investments
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
PreComb
PreComb collaborates with research partners by providing expert guidance in selecting and generating patient-derived 3D tumor models tailored to their studies.
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
Bricksave
A state-of-the-art crowdfunding platform providing direct access to secure, asset-backed investment opportunities hand-picked from across the globe.
BVNK
BVNK provides stablecoin payments infrastructure, unifying banks and blockchains in a single API platform, to accelerate global money movement.
Pocket Planet
Pocket Planet will be the UK's largest indoor miniature world, an immersive experience taking visitors on a journey through the UK & around the world.
ReBio
ReBio is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve.
CEBINA
A dynamic and forward-thinking organization, their mission is to foster the growth of early-stage life sciences ventures, cultivating innovation and advancing breakthroughs in medicine and technology.
Team
Nat Hutley
Partner
Leads the advisory business, working hands-on with founders to execute operational and financial transformations.
Iain Hubert
Partner
Heads fundraising and investor relations, ensuring the right capital partners are brought on board.
Galen Moore
Advisor
Oversees operations, strategy and execution to ensure businesses receive hands-on support.
Val Hutley
Junior Sales Associate
Focused on investor engagement and deal origination, helping to expand Koodos' network of self-certified and institutional investors.
Charles Agar
Junior Sales Associate
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Benjamin Harrison
Fundraising
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Establishing Koodos
Koodos transitions from a seed investment firm to a specialist advisory and investment platform, focusing on turnarounds and high-growth businesses.
We began by investing alongside family offices, co-investing in distressed and restructuring opportunities.
Expanding Fundraising Capabilities
Fundraising division launches, enabling self-certified investors to access high-potential distressed businesses. Built a network of introducers and brokers to scale investor access and expand deal flow.
Laying the Groundwork for Direct Investment
Strengthened focus on healthcare, biotech, and consumer growth businesses, identifying key opportunities for direct investment in 2024.
Investing in Life Sciences
2CureX partnership – Koodos begins supporting the precision oncology firm, leveraging its network to drive investor engagement and capital structuring.
Koodos invests in PreComb, a precision oncology driven genoid testing company, and actively supports its Series A fundraising.
Focus: Investor introductions, capital structuring, and strategic positioning.
Institutional Capital Discussions
Institutional investor interest in precision oncology businesses – potential £7m+ allocation for Koodos-backed companies.
Strengthening relationships with family offices and private equity investors.
Investing in Pocket Planet
Pocket Planet joins the portfolio – Koodos structures a carried interest agreement, securing long-term alignment on exit upside.
Focus: Market positioning, capital efficiency, and long-term scalability.
Scaling for Growth
Expanding the portfolio to 10+ businesses across biotech, consumer, and deep tech.
Transitioning towards a £50m dedicated fund to drive larger investments
Structuring faster, high value exits for existing investments.
We Transform Tech Businesses
£150k-£3m
9 Current Investments
Tech-Focussed
At Koodos, we invest in ambitious tech startups, providing the capital and support needed to fuel their growth. Our focus is on scalable companies in marketplaces, platforms, and software (SaaS) sectors.
What we do
We invest in and advise high-potential businesses undergoing transformation. Whether a company is distressed, underperforming, or struggling to scale, we step in with the expertise, capital, and strategic direction to turn things around.
Our model is simple: we partner with founders and management teams, working hands-on to restructure operations, optimise financials, and drive sustainable growth. The goal? Rapid recovery and high value exits within 2-3 years, whether through acquisitions, mergers, or private sales.
We focus on companies with strong fundamentals but untapped potential—businesses that need the right strategy, funding, and execution to succeed.
Current Investments
2cureX
2cureX is pioneering the use of functional drug sensitivity testing to improve the outcome of cancer treatments.
PreComb
PreComb collaborates with research partners by providing expert guidance in selecting and generating patient-derived 3D tumor models tailored to their studies.
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
Bricksave
A state-of-the-art crowdfunding platform providing direct access to secure, asset-backed investment opportunities hand-picked from across the globe.
BVNK
BVNK provides stablecoin payments infrastructure, unifying banks and blockchains in a single API platform, to accelerate global money movement.
Pocket Planet
Pocket Planet will be the UK's largest indoor miniature world, an immersive experience taking visitors on a journey through the UK & around the world.
ReBio
ReBio is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve.
CEBINA
A dynamic and forward-thinking organization, their mission is to foster the growth of early-stage life sciences ventures, cultivating innovation and advancing breakthroughs in medicine and technology.
Team
Nat Hutley
Partner
Leads the advisory business, working hands-on with founders to execute operational and financial transformations.
Iain Hubert
Partner
Heads fundraising and investor relations, ensuring the right capital partners are brought on board.
Galen Moore
Advisor
Oversees operations, strategy and execution to ensure businesses receive hands-on support.
Val Hutley
Junior Sales Associate
Focused on investor engagement and deal origination, helping to expand Koodos' network of self-certified and institutional investors.
Charles Agar
Junior Sales Associate
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Benjamin Harrison
Fundraising
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Establishing Koodos
Koodos transitions from a seed investment firm to a specialist advisory and investment platform, focusing on turnarounds and high-growth businesses.
We began by investing alongside family offices, co-investing in distressed and restructuring opportunities.
Expanding Fundraising Capabilities
Fundraising division launches, enabling self-certified investors to access high-potential distressed businesses. Built a network of introducers and brokers to scale investor access and expand deal flow.
Laying the Groundwork for Direct Investment
Strengthened focus on healthcare, biotech, and consumer growth businesses, identifying key opportunities for direct investment in 2024.
Investing in Life Sciences
2CureX partnership – Koodos begins supporting the precision oncology firm, leveraging its network to drive investor engagement and capital structuring.
Koodos invests in PreComb, a precision oncology driven genoid testing company, and actively supports its Series A fundraising.
Focus: Investor introductions, capital structuring, and strategic positioning.
Institutional Capital Discussions
Institutional investor interest in precision oncology businesses – potential £7m+ allocation for Koodos-backed companies.
Strengthening relationships with family offices and private equity investors.
Investing in Pocket Planet
Pocket Planet joins the portfolio – Koodos structures a carried interest agreement, securing long-term alignment on exit upside.
Focus: Market positioning, capital efficiency, and long-term scalability.
Scaling for Growth
Expanding the portfolio to 10+ businesses across biotech, consumer, and deep tech.
Transitioning towards a £50m dedicated fund to drive larger investments
Structuring faster, high value exits for existing investments.
Menu
Close
We Transform Tech Businesses
£150k-£3m
9 Current Investments
Tech-Focussed
At Koodos, we invest in ambitious tech startups, providing the capital and support needed to fuel their growth. Our focus is on scalable companies in marketplaces, platforms, and software (SaaS) sectors.
What we do
We invest in and advise high-potential businesses undergoing transformation. Whether a company is distressed, underperforming, or struggling to scale, we step in with the expertise, capital, and strategic direction to turn things around.
Our model is simple: we partner with founders and management teams, working hands-on to restructure operations, optimise financials, and drive sustainable growth. The goal? Rapid recovery and high value exits within 2-3 years, whether through acquisitions, mergers, or private sales.
We focus on companies with strong fundamentals but untapped potential—businesses that need the right strategy, funding, and execution to succeed.
Current Investments
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
PreComb
PreComb collaborates with research partners by providing expert guidance in selecting and generating patient-derived 3D tumor models tailored to their studies.
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
Bricksave
A state-of-the-art crowdfunding platform providing direct access to secure, asset-backed investment opportunities hand-picked from across the globe.
BVNK
BVNK provides stablecoin payments infrastructure, unifying banks and blockchains in a single API platform, to accelerate global money movement.
Pocket Planet
Pocket Planet will be the UK's largest indoor miniature world, an immersive experience taking visitors on a journey through the UK & around the world.
ReBio
ReBio is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve.
CEBINA
A dynamic and forward-thinking organization, their mission is to foster the growth of early-stage life sciences ventures, cultivating innovation and advancing breakthroughs in medicine and technology.
Team
Nat Hutley
Partner
Leads the advisory business, working hands-on with founders to execute operational and financial transformations.
Iain Hubert
Partner
Heads fundraising and investor relations, ensuring the right capital partners are brought on board.
Galen Moore
Advisor
Oversees operations, strategy and execution to ensure businesses receive hands-on support.
Val Hutley
Junior Sales Associate
Focused on investor engagement and deal origination, helping to expand Koodos' network of self-certified and institutional investors.
Charles Agar
Junior Sales Associate
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Benjamin Harrison
Fundraising
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Establishing Koodos
Koodos transitions from a seed investment firm to a specialist advisory and investment platform, focusing on turnarounds and high-growth businesses.
We began by investing alongside family offices, co-investing in distressed and restructuring opportunities.
Expanding Fundraising Capabilities
Fundraising division launches, enabling self-certified investors to access high-potential distressed businesses. Built a network of introducers and brokers to scale investor access and expand deal flow.
Laying the Groundwork for Direct Investment
Strengthened focus on healthcare, biotech, and consumer growth businesses, identifying key opportunities for direct investment in 2024.
Investing in Life Sciences
2CureX partnership – Koodos begins supporting the precision oncology firm, leveraging its network to drive investor engagement and capital structuring.
Koodos invests in PreComb, a precision oncology driven genoid testing company, and actively supports its Series A fundraising.
Focus: Investor introductions, capital structuring, and strategic positioning.
Institutional Capital Discussions
Institutional investor interest in precision oncology businesses – potential £7m+ allocation for Koodos-backed companies.
Strengthening relationships with family offices and private equity investors.
Investing in Pocket Planet
Pocket Planet joins the portfolio – Koodos structures a carried interest agreement, securing long-term alignment on exit upside.
Focus: Market positioning, capital efficiency, and long-term scalability.
Scaling for Growth
Expanding the portfolio to 10+ businesses across biotech, consumer, and deep tech.
Transitioning towards a £50m dedicated fund to drive larger investments
Structuring faster, high value exits for existing investments.
We Transform Tech Businesses
£150k-£3m
9 Current Investments
Tech-Focussed
At Koodos, we invest in ambitious tech startups, providing the capital and support needed to fuel their growth. Our focus is on scalable companies in marketplaces, platforms, and software (SaaS) sectors.
What we do
We invest in and advise high-potential businesses undergoing transformation. Whether a company is distressed, underperforming, or struggling to scale, we step in with the expertise, capital, and strategic direction to turn things around.
Our model is simple: we partner with founders and management teams, working hands-on to restructure operations, optimise financials, and drive sustainable growth. The goal? Rapid recovery and high value exits within 2-3 years, whether through acquisitions, mergers, or private sales.
We focus on companies with strong fundamentals but untapped potential—businesses that need the right strategy, funding, and execution to succeed.
Current Investments
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
PreComb
PreComb collaborates with research partners by providing expert guidance in selecting and generating patient-derived 3D tumor models tailored to their studies.
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
Bricksave
A state-of-the-art crowdfunding platform providing direct access to secure, asset-backed investment opportunities hand-picked from across the globe.
BVNK
BVNK provides stablecoin payments infrastructure, unifying banks and blockchains in a single API platform, to accelerate global money movement.
Pocket Planet
Pocket Planet will be the UK's largest indoor miniature world, an immersive experience taking visitors on a journey through the UK & around the world.
ReBio
ReBio is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve.
CEBINA
A dynamic and forward-thinking organization, their mission is to foster the growth of early-stage life sciences ventures, cultivating innovation and advancing breakthroughs in medicine and technology.
Team
Nat Hutley
Partner
Leads the advisory business, working hands-on with founders to execute operational and financial transformations.
Iain Hubert
Partner
Heads fundraising and investor relations, ensuring the right capital partners are brought on board.
Galen Moore
Advisor
Oversees operations, strategy and execution to ensure businesses receive hands-on support.
Val Hutley
Junior Sales Associate
Focused on investor engagement and deal origination, helping to expand Koodos' network of self-certified and institutional investors.
Charles Agar
Junior Sales Associate
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Benjamin Harrison
Fundraising
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Establishing Koodos
Koodos transitions from a seed investment firm to a specialist advisory and investment platform, focusing on turnarounds and high-growth businesses.
We began by investing alongside family offices, co-investing in distressed and restructuring opportunities.
Expanding Fundraising Capabilities
Fundraising division launches, enabling self-certified investors to access high-potential distressed businesses. Built a network of introducers and brokers to scale investor access and expand deal flow.
Laying the Groundwork for Direct Investment
Strengthened focus on healthcare, biotech, and consumer growth businesses, identifying key opportunities for direct investment in 2024.
Investing in Life Sciences
2CureX partnership – Koodos begins supporting the precision oncology firm, leveraging its network to drive investor engagement and capital structuring.
Koodos invests in PreComb, a precision oncology driven genoid testing company, and actively supports its Series A fundraising.
Focus: Investor introductions, capital structuring, and strategic positioning.
Institutional Capital Discussions
Institutional investor interest in precision oncology businesses – potential £7m+ allocation for Koodos-backed companies.
Strengthening relationships with family offices and private equity investors.
Investing in Pocket Planet
Pocket Planet joins the portfolio – Koodos structures a carried interest agreement, securing long-term alignment on exit upside.
Focus: Market positioning, capital efficiency, and long-term scalability.
Scaling for Growth
Expanding the portfolio to 10+ businesses across biotech, consumer, and deep tech.
Transitioning towards a £50m dedicated fund to drive larger investments
Structuring faster, high value exits for existing investments.
We Transform Tech Businesses
£150k-£3m
9 Current Investments
Tech-Focussed
At Koodos, we invest in ambitious tech startups, providing the capital and support needed to fuel their growth. Our focus is on scalable companies in marketplaces, platforms, and software (SaaS) sectors.
What we do
We invest in and advise high-potential businesses undergoing transformation. Whether a company is distressed, underperforming, or struggling to scale, we step in with the expertise, capital, and strategic direction to turn things around.
Our model is simple: we partner with founders and management teams, working hands-on to restructure operations, optimise financials, and drive sustainable growth. The goal? Rapid recovery and high value exits within 2-3 years, whether through acquisitions, mergers, or private sales.
We focus on companies with strong fundamentals but untapped potential—businesses that need the right strategy, funding, and execution to succeed.
Current Investments
2cureX
2cureX is pioneering the use of functional drug sensitivity testing to improve the outcome of cancer treatments.
PreComb
PreComb collaborates with research partners by providing expert guidance in selecting and generating patient-derived 3D tumor models tailored to their studies.
NativeWaves
A convenient and effective OTT streaming solution built to deliver not only standard content streams but also future-proofed to provide multi-view experiences.
Bricksave
A state-of-the-art crowdfunding platform providing direct access to secure, asset-backed investment opportunities hand-picked from across the globe.
BVNK
BVNK provides stablecoin payments infrastructure, unifying banks and blockchains in a single API platform, to accelerate global money movement.
Pocket Planet
Pocket Planet will be the UK's largest indoor miniature world, an immersive experience taking visitors on a journey through the UK & around the world.
ReBio
ReBio is a pre-clinical stage biotechnology company that has developed SiSu®, a novel, proprietary formulation technology that solves the safety and efficacy challenges other sustained release approaches have been unable to resolve.
CEBINA
A dynamic and forward-thinking organization, their mission is to foster the growth of early-stage life sciences ventures, cultivating innovation and advancing breakthroughs in medicine and technology.
Team
Nat Hutley
Partner
Leads the advisory business, working hands-on with founders to execute operational and financial transformations.
Iain Hubert
Partner
Heads fundraising and investor relations, ensuring the right capital partners are brought on board.
Galen Moore
Advisor
Oversees operations, strategy and execution to ensure businesses receive hands-on support.
Val Hutley
Junior Sales Associate
Focused on investor engagement and deal origination, helping to expand Koodos' network of self-certified and institutional investors.
Charles Agar
Junior Sales Associate
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Benjamin Harrison
Fundraising
Supporting fundraising efforts and investor relations, working closely with brokers and introducers to drive capital into high-growth businesses.
Establishing Koodos
Koodos transitions from a seed investment firm to a specialist advisory and investment platform, focusing on turnarounds and high-growth businesses.
We began by investing alongside family offices, co-investing in distressed and restructuring opportunities.
Expanding Fundraising Capabilities
Fundraising division launches, enabling self-certified investors to access high-potential distressed businesses. Built a network of introducers and brokers to scale investor access and expand deal flow.
Laying the Groundwork for Direct Investment
Strengthened focus on healthcare, biotech, and consumer growth businesses, identifying key opportunities for direct investment in 2024.
Investing in Life Sciences
2CureX partnership – Koodos begins supporting the precision oncology firm, leveraging its network to drive investor engagement and capital structuring.
Koodos invests in PreComb, a precision oncology driven genoid testing company, and actively supports its Series A fundraising.
Focus: Investor introductions, capital structuring, and strategic positioning.
Institutional Capital Discussions
Institutional investor interest in precision oncology businesses – potential £7m+ allocation for Koodos-backed companies.
Strengthening relationships with family offices and private equity investors.
Investing in Pocket Planet
Pocket Planet joins the portfolio – Koodos structures a carried interest agreement, securing long-term alignment on exit upside.
Focus: Market positioning, capital efficiency, and long-term scalability.
Scaling for Growth
Expanding the portfolio to 10+ businesses across biotech, consumer, and deep tech.
Transitioning towards a £50m dedicated fund to drive larger investments
Structuring faster, high value exits for existing investments.